UNICREDIT BANK/CALL/ABBVIE/200/0.1/15.01.25 Share Price

Warrant

DE000HC3LGA6

Market Closed - BOERSE MUENCHEN 01:12:24 01/06/2024 am IST
0.14 EUR +27.27% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/200/0.1/15.01.25
1 month-36.36%
3 months-76.67%
Date Price Change
31/24/31 0.14 +27.27%
30/24/30 0.11 -.--%
29/24/29 0.11 -.--%
28/24/28 0.11 -15.38%
27/24/27 0.13 -.--%

Real-time BOERSE MUENCHEN

Last update May 01, 2024 at 01:12 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LGA
ISINDE000HC3LGA6
Date issued 27/01/2023
Strike 200 $
Maturity 15/01/2025 (228 Days)
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.83
Lowest since issue 0.093
Delta0.13x
Omega 12.03
Premium25.15x
Gearing90.09x
Moneyness 0.8062
Difference Strike 38.76 $
Difference Strike %+19.38%
Spread 0.01
Spread %5.88%
Theoretical value 0.1750
Implied Volatility 22.71 %
Total Loss Probability 89.48 %
Intrinsic value 0.000000
Present value 0.1750
Break even 201.90 €
Theta-0.01x
Vega0.03x
Rho0.01x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
161.2 USD
Average target price
182.1 USD
Spread / Average Target
+12.95%
Consensus